Doctor profile · Federal record
Dr. Mark Wells, M.D.
Gastroenterology Physician (CMS: Gastroenterology) · Internal Medicine Physician · Lincoln, NE
- NPI 1932319316
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 19 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4545 R St Ste 100
Lincoln, NE 685033799
(402) 465-4545
fax (402) 465-9011
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- July 21, 2022
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State licenses (2)
- Nebraska #30063 · Arkansas #E-6563
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932319316. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,960
Distinct HCPCS
10
Medicare allowed
$328,086
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 7,800 | 22 | $22 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,230 | 20 | $32 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 220 | 219 | $229 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 113 | 62 | $75 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 92 | 88 | $99 | |
G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 78 | 76 | $5 | |
43235 |
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | 66 | $99 | |
G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk | 51 | 51 | $164 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 43 | 43 | $122 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 31 | 31 | $107 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 428. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$16
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Celgene Corporation | 1 | $15.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
927
Patients
403
Total drug cost
$71,135
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 329 | 92 | $7,144 |
| Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl) | Brand | 125 | 124 | $2,201 |
| Omeprazole | Generic | 103 | 23 | $1,978 |
| Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates) | Brand | 63 | 62 | $5,020 |
| Colestipol Hcl | Generic | 45 | 16 | $2,941 |
| Peg-3350 And Electrolytes (Peg3350/Sod Sulf,bicarb,cl/Kcl) | Brand | 39 | 35 | $709 |
| Plenvu (Peg3350/Sod Sul/Nacl/Kcl/Asb/C) | Brand | 39 | 39 | $5,841 |
| Linzess (Linaclotide) | Brand | 36 | 0 | $27,843 |
| Sucralfate | Generic | 31 | 12 | $2,098 |
| Dicyclomine Hcl | Generic | 22 | 0 | $373 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Wells's medical specialty?
Dr. Mark Wells practices Gastroenterology Physician in Lincoln, NE.
Where does Dr. Mark Wells practice?
Dr. Mark Wells practices at 4545 R St Ste 100, Lincoln, NE 685033799. Office phone: 4024654545.
What is Dr. Mark Wells's NPI?
Dr. Mark Wells's National Provider Identifier (NPI) is 1932319316, issued by NPPES.
Does Dr. Mark Wells accept Medicare assignment?
Yes. Dr. Mark Wells accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Wells commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Removal of polyps or growths of large bowel using an endoscope with mechanical snare (HCPCS 45385). Source: CMS Medicare Physician & Other Practitioners file.